Transgender, non-binary, gender-diverse people more likely to have a long-term mental health condition, says study

A study from The Lancet Public Health journal found that transgender, non-binary, and gender-diverse people in England are at a higher risk for developing long-term mental health conditions than cisgender individuals. The research combined data from the English GP Patient Survey and analyzed responses from over 1.5 million participants. The study found that approximately half…

Read More

Happy Weight vs. Healthy Weight

April Williams experienced significant weight loss through surgery, diet, exercise, and medication. She struggled with disheartening plateaus and societal standards of weight and body image. The focus on weight and BMI can lead to distorted body image and unrealistic goals. Maintaining a healthy weight involves lifestyle habits and overall health, rather than hitting a specific…

Read More

FDA Okays Boston Scientific PFA System for Paroxysmal AF

The Farapulse Pulsed Field Ablation (PFA) system by Boston Scientific has received FDA approval for treating drug-refractory, recurrent, symptomatic, paroxysmal atrial fibrillation (AF). This system is an alternative to standard thermal ablation, using tissue-selective, nonthermal electric fields to ablate heart tissue. Clinical trial data shows the Farapulse system is as safe and effective as traditional…

Read More

Age-Defying Elixir For Radiant Skin

Retinol serum is a powerful skincare product known for its anti-aging properties and ability to promote skin renewal by reducing fine lines and wrinkles. Here are the best retinol serums based on user reviews and ratings: 1. The Ordinary Retinol 1% in Squalane 2. Paula’s Choice 1% Retinol Treatment 3. Neutrogena Rapid Wrinkle Repair Retinol…

Read More

Biogen Says Goodbye to Beleaguered Alzheimer’s Drug Aduhelm

Biogen has announced that it is cutting ties with the Alzheimer’s drug Aduhelm, discontinuing its development and commercialization. The drug, which had controversial regulatory approval, was a commercial failure due to low market uptake, safety concerns, and limited insurance coverage. The company is also terminating a post-marketing confirmatory study and has returned the drug’s rights…

Read More

Accompany Health launches with $56M to care for low-income patients

Accompany Health, a Bethesda-based care provider, has secured $56 million in Series A funding to offer in-home and virtual care services for low-income patients with complex needs. Services include primary and urgent care, mental health, social care, transportation to medical appointments, assistance with benefit applications, and health coaching. The company aims to address the serious…

Read More